Publications of Peter Falkai

Theisen, C.; Rosen, M.; Meisenzahl, E.; Koutsouleris, N.; Lichtenstein, T.; Ruhrmann, S.; Kambeitz, J.; Kambeitz-Ilankovic, L.; Riecher-Roessler, A.; Chisholm, K. et al.; Upthegrove, R.; Antonucci, L. A. A.; Bertolino, A.; Pigoni, A.; Salokangas, R. K. R.; Pantelis, C.; Wood, S. J. J.; Lencer, R.; Falkai, P.; Hietala, J.; Brambilla, P.; Schmidt, A.; Andreou, C.; Borgwardt, S.; Osman, N.; Schultze-Lutter, F.; PRONIA, C.: The heterogeneity of attenuated and brief limited psychotic symptoms: association of contents with age, sex, country, religion, comorbidities, and functioning. FRONTIERS IN PSYCHIATRY 14, 1209485 (2023)

Boudriot, E.; Schworm, B.; Slapakova, L.; Hanken, K.; Jaeger, I.; Stephan, M.; Gabriel, V.; Ioannou, G.; Melcher, J.; Hasanaj, G. et al.; Campana, M.; Moussiopoulou, J.; Loehrs, L.; Hasan, A.; Falkai, P.; Pogarell, O.; Priglinger, S.; Keeser, D.; Kern, C.; Wagner, E.; Raabe, F. J.: Optical coherence tomography reveals retinal thinning in schizophrenia spectrum disorders. EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE (2022)

Maurus, I.; Roell, L.; Keeser, D.; Papazov, B.; Papazova, I.; Lembeck, M.; Roeh, A.; Wagner, E.; Hirjak, D.; Malchow, B. et al.; Ertl-Wagner, B.; Stoecklein, S.; Hasan, A.; Schmitt, A.; Meyer-Lindenberg, A.; Falkai, P.: Fitness is positively associated with hippocampal formation subfield volumes in schizophrenia: a multiparametric magnetic resonance imaging study. TRANSLATIONAL PSYCHIATRY 12 (1), 388 (2022)

Schmitt, A.; Tatsch, L.; Vollhardt, A.; Schneider-Axmann, T.; Raabe, F. J.; Roell, L.; Heinsen, H.; Hof, P. R.; Falkai, P.; Schmitz, C.: Decreased Oligodendrocyte Number in Hippocampal Subfield CA4 in Schizophrenia: A Replication Study. CELLS 11 (20), 3242 (2022)

Schmitt, A.; Uhrig, S.; Spanagel, R.; von Wilmsdorff, M.; Kalman, J. L.; Schneider-Axmann, T.; Falkai, P.; Hansson, A. C.: Post-mortem gene expression of calcium channels Cav1.2 and Cav1.3 in schizophrenia. EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE 272 (7), pp. 1135 - 1137 (2022)

Stephan, M.; Schoeller, J.; Raabe, F. J.; Schmitt, A.; Hasan, A.; Falkai, P.; Jensen, N.; Rossner, M. J.: Spironolactone alleviates schizophrenia-related reversal learning in Tcf4 transgenic mice subjected to social defeat. SCHIZOPHRENIA 8 (1), 77 (2022)

Koutsouleris, N.; Dwyer, D. B.; Degenhardt, F.; Maj, C.; Urquijo-Castro, M. F.; Sanfelici, R.; Popovic, D.; Oeztuerk, O.; Haas, S. S.; Weiske, J. et al.; Ruef, A.; Kambeitz-Ilankovic, L.; Antonucci, L. A.; Neufang, S.; Schmidt-Kraepelin, C.; Ruhrmann, S.; Penzel, N.; Kambeitz, J.; Haidl, T. K.; Rosen, M.; Chisholm, K.; Riecher-Rossler, A.; Egloff, L.; Schmidt, A.; Andreou, C.; Hietala, J.; Schirmer, T.; Romer, G.; Walger, P.; Franscini, M.; Traber-Walker, N.; Schimmelmann, B. G.; Fluckiger, R.; Michel, C.; Rossler, W.; Borisov, O.; Krawitz, P. M.; Heekeren, K.; Buechler, R.; Pantelis, C.; Falkai, P.; Salokangas, R. K. R.; Lencer, R.; Bertolino, A.; Borgwardt, S.; Noethen, M.; Brambilla, P.; Wood, S. J.; Upthegrove, R.; Schultze-Lutter, F.; Theodoridou, A.; Meisenzahl, E.: Multimodal Machine Learning Workflows for Prediction of Psychosis in Patients With Clinical High-Risk Syndromes and Recent-Onset Depression. JAMA PSYCHIATRY 78 (2), pp. 195 - 209 (2021)

Sanfelici, R.; Ruef, A.; Antonucci, L. A.; Penzel, N.; Sotiras, A.; Sen Dong, M.; Urquijo-Castro, M.; Wenzel, J.; Kambeitz-Ilankovic, L.; Hettwer, M. D. et al.; Ruhrmann, S.; Chisholm, K.; Riecher-Rossler, A.; Falkai, P.; Pantelis, C.; Salokangas, R. K. R.; Lencer, R.; Bertolino, A.; Kambeitz, J.; Meisenzahl, E.; Borgwardt, S.; Brambilla, P.; Wood, S. J.; Upthegrove, R.; Schultze-Lutter, F.; Koutsouleris, N.; Dwyer, D. B.: Novel Gyrification Networks Reveal Links with Psychiatric Risk Factors in Early Illness. CEREBRAL CORTEX (2021)

Popovic, D.; Schiltz, K.; Falkai, P.; Koutsouleris, N.: Precision Psychiatry and the Contribution of Brain Imaging and Other Biomarkers. FORTSCHRITTE DER NEUROLOGIE PSYCHIATRIE 88 (12), pp. 778 - 785 (2020)

Neuner, L. -.; Hahn, L.; Kambeitz, J.; Salokangas, R. K.; Hietala, J.; Bertolino, A.; Borgwardt, S.; Brambilla, P.; Upthegrove, R.; Wood, S. J. et al.; Lencer, R.; Meisenzahl, E.; Falkai, P.; Cannon, T. D.; Koutsouleris, N.: Exploring Associations between Grey Matter Volume and Clinical High-Risk for Psychosis: A Transdiagnostic Study Utilizing the NAPLS-2 Risk Calculator in the PRONIA Cohort. In EUROPEAN PSYCHIATRY, 67, pp. S271 - S272. (2024)

Schoenweger, P.; Eder, J.; Pfeiffer, L.; Falkai, P.; Kirschneck, M.; Brunoni, A.; Gensichen, J.; Ditzen-Janotta, C.; Simon, M. S.; Jung-Sievers, C.: Measuring social environment factors of depressed inpatients: A cross-sectional study. In EUROPEAN JOURNAL OF PUBLIC HEALTH, 34 (Supplement_3), ckae144.972. (2024)

Weyer, C.; Popovic, D.; Ruef, A.; Hahn, L.; Sarisik, E.; Fanning, J.; Kambeitz, J.; Salokangas, R. K.; Hietala, J.; Bertolino, A. et al.; Borgwardt, S.; Brambilla, P.; Upthegrove, R.; Wood, S. J.; Lencer, R.; Meisenzahl, E.; Falkai, P.; Koutsouleris, N.: Multivariate associations between psychiatric drug intake and grey matter volume changes in individuals at early stages of psychosis and depression. In EUROPEAN PSYCHIATRY, 67, pp. S272 - S273. (2024)

Kambeitz-Ilankovic, L.; Strube, W.; Baune, B. T.; Falkai, P.; Roell, L.; Leucht, S.: Cognitive impairments associated with schizophrenic psychoses Diagnostics, course and therapy. NERVENARZT (2024)

Halil, M. G.; Baskow, I.; Zimdahl, M. F.; Lipinski, S.; Hannig, R.; Falkai, P.; Fallgatter, A. J.; Schneider, S.; Walter, M.; Meyer-Lindenberg, A. et al.; Heinz, A.: The German Center for Mental Health. Innovative translational research to promote prevention, targeted intervention and resilience. NERVENARZT (2024)

Maurus, I.; Wagner, S.; Spaeth, J.; Vogel, A.; Muenz, S.; Seitz, V.; von Philipsborn, P.; Solmi, M.; Firth, J.; Stubbs, B. et al.; Vancampfort, D.; Hallgren, M.; Kurimay, T.; Gerber, M.; Correll, C. U.; Gaebel, W.; Moeller, H.-J.; Schmitt, A.; Hasan, A.; Falkai, P.: EPA guidance on lifestyle interventions for adults with severe mental illness: A meta-review of the evidence. EUROPEAN PSYCHIATRY 67 (1), e80 (2024)

Falkai, P.; Schwaiger, R.; Schmitt, A.; Roell, L.; Maurus, I.: Sports Therapy for Schizophrenia Psychoses: from the Idea to the Guideline. GESUNDHEITSWESEN 85, pp. S212 - S217 (2023)

Schmitt, A.; Falkai, P.; Papiol, S.: Neurodevelopmental disturbances in schizophrenia: evidence from genetic and environmental factors. JOURNAL OF NEURAL TRANSMISSION (2022)

Schmitt, A.; Röll, L.; Maurus, I.; Falkai, P.: Aerobic exercise therapy in severe mental disorders: from methods to underlying mechanisms. European archives of psychiatry and clinical neuroscience (2025)

Papiol, S.; Roell, L.; Maurus, I.; Hirjak, D.; Keeser, D.; Schmitt, A.; Meyer-Lindenberg, A.; Falkai, P.: Cell type-specific polygenic burden modulates exercise effects in schizophrenia patients: further evidence on volumes of hippocampal subfields. EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE (2024)

Schmitt, A.; Maurus, I.; Falkai, P.: Treatment of negative symptoms in schizophrenia: a challenge for clinical research. EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE 273, pp. 525 - 526 (2023)